Navigation Links
BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
Date:5/28/2009

Toronto Stock Exchange Symbol: MS

EDMONTON, May 28 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Randy Stroud, Vice President Regulatory Affairs, will present at the Canadian Society for Pharmaceutical Sciences 12th Annual Meeting & Symposium.

    TITLE:       "Dirucotide: A Potential Therapy for Multiple Sclerosis"

    WHEN:        Thursday June 4th at 2:00 pm (Eastern Time)

    WHERE:       Hyatt Regency Hotel, Toronto, Ontario, Canada

    About the Canadian Society for Pharmaceutical Sciences (CSPS)
    -------------------------------------------------------------

CSPS is the premier organization for bringing together Pharmaceutical Scientists across Canada. The 12th Annual Meeting & Symposium focus is "Drug Development to Regulatory Approval". For further information, please visit: http://www.cspscanada.org/symposium2009.aspx.

    About BioMS Medical Corp.
    -------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for Secondary Progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide in exchange for an upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-l
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC B...-of-the-art genetic analysis systems, today announ...ompany,s Scientific Advisory Board. His career ha...vel molecular diagnostics for cancer detection and...putational biology systems for several biotechnolo...
(Date:11/5/2009)...5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corp...ompany") today announced,that the Company plans to...onday, November 9, 2009, after the market closes. ... at 5:00 pm ET on November 9, 2009,to discuss thir...call by,dialing 1-888-713-4211 or 1-617-213-4864 f...
(Date:11/5/2009)...y and vision correction experts listed in the Trus...d at the recently concluded American Academy of Op...isco, California. Dr. Stephen Brint, MD, Dr. Frede...r. Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr. ...dward Manche, MD, and Dr. Parag Majmudar, MD, all ...
(Date:11/4/2009)..., which will be presented on November 19 and is of...mistry processing, will deal with the application ... and micro scale flow chemistry equipment. Profes...ecognized with several prestigious prizes and awar...rize. , Columbia, MD (PRW...
Breaking Biology Technology:WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...; 2 to 3 children in 100 are born with a mental ha...t in 80% of the cases scientists do not know which...cted to the Katholieke Universiteit Leuven, in col...discovered that, in a portion of these patients, t...ction of two proteins (HSD17B10 and HUWE1). This i...
.... 24 Cardica, Inc.,(Nasdaq: CRDC ) today reporte... fiscal 2008 second quarter and six months ended D... commercial progress, with over 1,000,C-Port syste... an expanding,product line designed to enable mini...ancement for our development-stage products," said...
...rgest Chemically Defined Structure Synthesized,in ... Process to Create Synthetic,Organism, ROCKVILLE,...Craig Venter Institute (JCVI) has created the larg...embling the 582,970 base pair,genome of a bacteriu...ished,online today in the journal Science by Dan G...
Other Biology Technology:Discovery of new cause of mental retardation simplifies search for treatments 2Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress 2Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress 3Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress 4Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress 5Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress 6Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress 7Venter Institute Scientists Create First Synthetic Bacterial Genome 2Venter Institute Scientists Create First Synthetic Bacterial Genome 3Venter Institute Scientists Create First Synthetic Bacterial Genome 4Venter Institute Scientists Create First Synthetic Bacterial Genome 5Venter Institute Scientists Create First Synthetic Bacterial Genome 6
(Date:11/3/2009)...BER 4, 2009 -- The world,s greatest wines are the..., human input, and something called the "terroir" ..., and climate. , Experts will discuss terroir ... Wednesday, Nov. 4 in Pittsburgh. "Terroir: Wineg...o parts at the 2009 Annual Meetings of the America...
(Date:11/3/2009)... a research report published in a recent issue of ...im Alegre examined the effects of covering orchard...t quality, canopy light distribution, orchard temp...erformed using Extenday and Solarmate films instal...of ,Mondial Gala, apples. The research showed that...
(Date:11/3/2009)...AYETTE, Ind. - Chief executives in 35 of the top F...mes their "ideal salaries" in 2008, according to a...rdue University researcher to determine fair CEO c...c and corporate governance issues of the day is ho...enkat Venkatasubramanian, a professor of chemical ...
Breaking Biology News(10 mins):Great wines come from great soils 2Reflective film can boost profits for apple growers 2New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 1Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 2Master Stem Cell for Human Heart Identified 50565 1Master Stem Cell for Human Heart Identified 50565 2Master Stem Cell for Human Heart Identified 50565 3Nation Takes a Big Step Toward Learning Which Medical Treatments Work Best a Major Advance in Fixing Our Broken Health Care System 50562 1Nation Takes a Big Step Toward Learning Which Medical Treatments Work Best a Major Advance in Fixing Our Broken Health Care System 50562 2
...ne in their desire to conform to cultural norms, a...he first time, chimpanzees share the same conformi...mpanzee communities share and maintain traditions,...opy their peers well into adulthood and say that a..., the level of cultural variation shown by chimpan...
...virus that introduces a blood pressure-lowering ge...ood pressure at healthy levels for four months pro... closer to reality, said researchers at Baylor Col...e Proceedings of the National Academy of Sciences....es of death and disability in adults worldwide," s...
...e marrow cells that produce insulin appear to caus...at disables many people with diabetes, said a rese...ston. , The report from researchers at BCM, Shiga ...iversity of Chicago appears online today in the Pr...The finding not only provides a basis for understa...
Other Biology News:Cultural norms not unique to human societies 2Gene therapy to lower blood pressure just enough 2Malfunctioning bone marrow cells sabotage nerve cells in diabetes 2
Xylene Cyanole FF from Sigma-Aldrich
... The VSOS-4 Orbital Shaker is designed to be a so...a uniform motion that is both mixing and vortexing...a smooth, quiet, reproducible and uniform orbital ... laboratory applications such as cell/tissue cultu...
... The Biometra TProfessional Thermocycler combines ... silver block achieves high speed and unparalleled...graphical display providing programming in a sprea...igh Performance Smart Lid opens on the push of a b...
... The Synaptic Vesicles Isolation Kit provides all ...naptic vesicle fraction. The isolation procedure i...of the synaptosomes, and differential centrifugati...it also contains an antibody specific for synaptop...
Biology Products: